Keyphrases
Hospitalization Risk
100%
Phosphate Binder
100%
Sevelamer Hydrochloride
100%
Renagel
100%
Medicaid Patients
57%
Medicare Spending
28%
Clinical Trials
14%
Long-term Safety
14%
Long-term Efficacy
14%
Randomized Clinical Trial
14%
Hospitalization
14%
Case-controlled Study
14%
Serum Calcium
14%
Comorbid Conditions
14%
Between-group
14%
Relative Risk
14%
Baseline Characteristics
14%
Cox Regression Model
14%
First Hospitalization
14%
Potential Bias
14%
Lipid Profile
14%
Maintenance Hemodialysis Patients
14%
Calcium-phosphorus Product
14%
Dialysis Facility
14%
Sevelamer
14%
All-cause Hospitalization
14%
Diabetes Distress
14%
Product Profile
14%
Dialysis Time
14%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Lipid Profile
100%
Randomized Clinical Trial
100%
Calcium Blood Level
100%
Hemodialysis
100%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphate Binding Agent
100%
Sevelamer
100%
Clinical Trial
10%
Randomized Clinical Trial
10%
Hemodialysis
10%